These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4366990)

  • 1. Antibodies to herpes group viruses in patients with nasopharyngeal and other head and neck cancers.
    Henderson BE; Louie E; Bogdanoff E; Henie W; Alena B; Henie G
    Cancer Res; 1974 May; 34(5):1207-10. PubMed ID: 4366990
    [No Abstract]   [Full Text] [Related]  

  • 2. Epstein-Barr virus is not associated with head and neck neoplasms other than nasopharyngeal carcinoma.
    Kottaridis SD; Goula I; Kiparissiadis P
    Neoplasma; 1982; 29(3):327-31. PubMed ID: 6290911
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunologic detection of occult primary cancer of the head and neck.
    Neel HB; Pearson GR; Weiland LH; Taylor WF; Goepfert HH
    Otolaryngol Head Neck Surg; 1981; 89(2):230-4. PubMed ID: 6264367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroepidemiological studies on carcinoma of the nasopharynx.
    Lin TM; Yang CS; Chiou JF; Tu SM; Lin CC; Liu CH; Chen KP; Ito Y; Kawamura A; Hirayama T
    Cancer Res; 1973 Nov; 33(11):2603-8. PubMed ID: 4355974
    [No Abstract]   [Full Text] [Related]  

  • 5. Nasopharyngeal carcinoma (NPC). VI. Presence of an EBV nuclear antigen in fresh tumour biopsies. Preliminary results.
    de Thé G; Ablashi DV; Liabeuf A; Mourali N
    Biomedicine; 1973 Aug; 19(8):349-52. PubMed ID: 4359467
    [No Abstract]   [Full Text] [Related]  

  • 6. Nasopharyngeal carcinoma and Epstein-Barr virus. II. Clinical course and the anti-VCA antibody.
    Lynn T; Tu S; Hirayama T; Kawamura A
    Jpn J Exp Med; 1973 Apr; 43(2):135-44. PubMed ID: 4352112
    [No Abstract]   [Full Text] [Related]  

  • 7. Nasopharyngeal carcinoma and Epstein-Barr virus. I. Factors related to the anti-VCA antibody.
    Lynn T; Tu S; Hirayama T; Kawamura A
    Jpn J Exp Med; 1973 Apr; 43(2):121-33. PubMed ID: 4352111
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups.
    Henle W; Henle G; Ho HC; Burtin P; Cachin Y; Clifford P; de Schryver A; de-Thé G; Diehl V; Klein G
    J Natl Cancer Inst; 1970 Jan; 44(1):225-31. PubMed ID: 11515035
    [No Abstract]   [Full Text] [Related]  

  • 9. Herpes viruses and oncogenesis.
    Klein G
    Johns Hopkins Med J Suppl; 1974; 3():15-25. PubMed ID: 4370988
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-barr-virus nuclear antigen.
    Vonka V; Hirsch I
    Prog Med Virol; 1982; 28():145-79. PubMed ID: 6283600
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of the Epstein-Barr herpesvirus relationship with Hodgkin's disease and the use of virus immunological markers in differential diagnostics of nasopharyngeal carcinoma.
    Mazurenko NP; Gurtsevich VE; Stepina VN; Plakhov IV
    Arch Geschwulstforsch; 1983; 53(3):253-9. PubMed ID: 6311138
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-EB virus titer in serum of patients with otorhinolaryngology cancer].
    Hosokawa T
    Nihon Jibiinkoka Gakkai Kaiho; 1970 Sep; 73(9):1533-6. PubMed ID: 4319400
    [No Abstract]   [Full Text] [Related]  

  • 13. Epstein-Barr Virus antibodies in patients with carcinoma of the nasopharynx and carcinoma of other sites in the head and neck.
    Sako K; Minowada J; Marchetta FC
    Am J Surg; 1975 Oct; 130(4):437-9. PubMed ID: 170838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of EBNA in nasopharyngeal carcinoma and control patient tissues related to EBV serology.
    Huang DP; Ho HC; Henle W; Henle G; Saw D; Lui M
    Int J Cancer; 1978 Sep; 22(3):266-74. PubMed ID: 212372
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on antibody surveillance to EB virus-induced antigen in patients with sarcoidosis and nasopharyngeal carcinoma by indirect immunofluorescence.
    Naito M; Akiyama Y; Kato S; Tachibana T; Sakai T
    Biken J; 1973 Dec; 16(4):141-8. PubMed ID: 4363326
    [No Abstract]   [Full Text] [Related]  

  • 16. High anti-EB virus titer in sera of patients with nasopharyngeal carcinoma: a small-scaled seroepidemiological study.
    Ito Y; Takahashi T; Kawamura A; Tu SM
    Gan; 1969 Jun; 60(3):335-40. PubMed ID: 4899471
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibodies to herpes-type virus in nasopharyngeal carcinoma and control groups.
    Lin TM; Yang CS; Ho SW; Chiou JF; Liu CH; Tu SM; Chen KP; Ito YH; Kawamura A; Hirayama T
    Cancer; 1972 Mar; 29(3):603-9. PubMed ID: 4334237
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relationship between changes of 3 types of anti-EB virus antibodies in the serum of patients with nasopharyngeal cancer and their clinical courses].
    Terayama Y; Ueno M; Kamata N; Jinnai I; Sasaki Y
    Nihon Jibiinkoka Gakkai Kaiho; 1972 Oct; 75(10):1079-80. PubMed ID: 4120228
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum anti-EBV IgA is inversely related to tumor infiltration by surface IgA positive lymphocytes in nasopharyngeal carcinoma.
    Gunvén P; Klein G; Henle W; Henle G; Forsby N
    Biomed Pharmacother; 1983; 37(1):41-4. PubMed ID: 6311307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunologic basis for detection of occult primary malignancies of the head and neck.
    Coates HL; Pearson GR; Neel HB; Weiland LH; Devine KD
    Cancer; 1978 Mar; 41(3):912-8. PubMed ID: 205337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.